|
DUOX1 Inhibitors for Treatment of Allergic Disorders
Current treatments for allergic diseases such as asthma, atopic eczema and psoriasis are still not effective for 10% of the millions of patients worldwide with these diseases. Dual oxidase (DUOX1) is a member of the NADPH oxidase family and is a critical mediator of innate immune response to allergens. Several thiol-reactive electrophiles have been...
Published: 2/25/2025
|
Inventor(s): Albert van der Vliet, David Heppner, Karamatullah Danyal
Keywords(s):
Category(s): Technology Classifications > Biomedical
|
